Landscapes / Companies
Conjupro Biotherapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 1
Drugs
3
in active trials · 8 in all
Trials
3 active
9 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
CPO301not checked |
— |
Phase 1 | May 2027Phase 1 trial completes | ||
| Next date | May 2027 · Phase 1 trial completes | ||||
| Also tested for | Cancer, Cancer, Lung | ||||
| Open drug page | |||||
— |
Phase 1 | Jul 2029Phase 1 trial completes | |||
| Next date | Jul 2029 · Phase 1 trial completes | ||||
| Also tested for | Cancer, Cancer (Solid Tumors) | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2029Phase 1 trial completes | |||
| Next date | Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Cancer, Solid Tumor Cancer and 5 more | ||||
| Open drug page | |||||
About
- No active trial
- CPO-100, CPO102, HA115, JMT601, NBP Softgel
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021